$INTA
Intapp, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024123292 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $118.8M $101.6M
YoY Change 16.96% 27.71%
Cost Of Revenue $31.93M $31.57M
YoY Change 1.14% 24.63%
Gross Profit $86.87M $70.00M
YoY Change 24.1% 29.15%
Gross Profit Margin 73.12% 68.92%
Selling, General & Admin $61.70M $55.47M
YoY Change 11.23% 7.25%
% of Gross Profit 71.02% 79.24%
Research & Development $32.43M $28.50M
YoY Change 13.79% 44.8%
% of Gross Profit 37.33% 40.71%
Depreciation & Amortization $4.467M $4.009M
YoY Change 11.42% -2.6%
% of Gross Profit 5.14% 5.73%
Operating Expenses $94.13M $83.97M
YoY Change 12.1% 14.47%
Operating Profit -$7.254M -$13.97M
YoY Change -48.06% -27.06%
Interest Expense $3.422M $39.00K
YoY Change 8674.36% 0.0%
% of Operating Profit
Other Income/Expense, Net $3.422M -$904.0K
YoY Change -478.54% 32.16%
Pretax Income -$3.832M -$14.91M
YoY Change -74.3% -24.97%
Income Tax $688.0K $413.0K
% Of Pretax Income
Net Earnings -$4.520M -$15.32M
YoY Change -70.5% -23.6%
Net Earnings / Revenue -3.8% -15.08%
Basic Earnings Per Share -$0.06 -$0.22
Diluted Earnings Per Share -$0.06 -$0.22
COMMON SHARES
Basic Shares Outstanding 77.39M 74.70M 69.24M
Diluted Shares Outstanding 75.60M 68.94M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $253.8M $141.5M
YoY Change 79.4% 250.9%
Cash & Equivalents $253.8M $141.5M
Short-Term Investments
Other Short-Term Assets $25.17M $21.30M
YoY Change 18.18% -7.65%
Inventory
Prepaid Expenses $11.29M $8.972M
Receivables $74.83M $68.82M
Other Receivables $2.732M $500.0K
Total Short-Term Assets $356.6M $246.7M
YoY Change 44.52% 95.88%
LONG-TERM ASSETS
Property, Plant & Equipment $39.47M $17.70M
YoY Change 123.06% 25.93%
Goodwill $286.5M $278.6M
YoY Change 2.83% 3.48%
Intangibles $37.29M $40.55M
YoY Change -8.04% -10.58%
Long-Term Investments
YoY Change
Other Assets $22.61M $1.818M
YoY Change 1143.51% -28.43%
Total Long-Term Assets $385.8M $370.9M
YoY Change 4.04% 2.07%
TOTAL ASSETS
Total Short-Term Assets $356.6M $246.7M
Total Long-Term Assets $385.8M $370.9M
Total Assets $742.4M $617.6M
YoY Change 20.21% 26.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.01M $6.185M
YoY Change 158.9% 36.26%
Accrued Expenses $42.56M $13.37M
YoY Change 218.33% 75.93%
Deferred Revenue $203.1M $191.4M
YoY Change 6.1% 26.55%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $273.3M $244.1M
YoY Change 11.95% 15.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $25.74M $9.325M
YoY Change 176.08% 23.27%
Total Long-Term Liabilities $25.74M $9.325M
YoY Change 176.08% 23.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $273.3M $244.1M
Total Long-Term Liabilities $25.74M $9.325M
Total Liabilities $300.3M $270.9M
YoY Change 10.85% 13.42%
SHAREHOLDERS EQUITY
Retained Earnings -$491.7M -$470.5M
YoY Change 4.51% 15.94%
Common Stock $78.00K $69.00K
YoY Change 13.04% 9.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $442.1M $346.7M
YoY Change
Total Liabilities & Shareholders Equity $742.4M $617.6M
YoY Change 20.21% 26.22%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$4.520M -$15.32M
YoY Change -70.5% -23.6%
Depreciation, Depletion And Amortization $4.467M $4.009M
YoY Change 11.42% -2.6%
Cash From Operating Activities $24.45M $11.61M
YoY Change 110.52% 261.18%
INVESTING ACTIVITIES
Capital Expenditures $1.888M $1.141M
YoY Change 65.47% -31.59%
Acquisitions $897.0K $0.00
YoY Change
Other Investing Activities -$897.0K
YoY Change
Cash From Investing Activities -$2.785M -$3.002M
YoY Change -7.23% 2.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.53M 1.691M
YoY Change 1173.27% -117.31%
NET CHANGE
Cash From Operating Activities 24.45M 11.61M
Cash From Investing Activities -2.785M -3.002M
Cash From Financing Activities 21.53M 1.691M
Net Change In Cash 43.19M 10.56M
YoY Change 308.94% -200.99%
FREE CASH FLOW
Cash From Operating Activities $24.45M $11.61M
Capital Expenditures $1.888M $1.141M
Free Cash Flow $22.56M $10.47M
YoY Change 115.43% 576.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001565687
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 inta Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
001-40550
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
Intapp, Inc.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1467620
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
3101 Park Blvd
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94306
CY2024Q3 dei City Area Code
CityAreaCode
650
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
852-0400
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q3 dei Trading Symbol
TradingSymbol
INTA
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77385502
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253847000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208370000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1117000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1406000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62053000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95103000
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
12777000
CY2024Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
13300000
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2732000
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2743000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11294000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9031000
CY2024Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13678000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13907000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
356581000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
342654000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19441000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18944000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20030000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21382000
CY2024Q3 us-gaap Goodwill
Goodwill
286472000
CY2024Q2 us-gaap Goodwill
Goodwill
285969000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37291000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40293000
CY2024Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
17057000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
18495000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5550000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5262000
CY2024Q3 us-gaap Assets
Assets
742422000
CY2024Q2 us-gaap Assets
Assets
732999000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16013000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13348000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33958000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42066000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8600000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12040000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
203114000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
218923000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11575000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14270000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
273260000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
300647000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1298000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1336000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2097000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3563000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18626000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19605000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5021000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4610000
CY2024Q3 us-gaap Liabilities
Liabilities
300302000
CY2024Q2 us-gaap Liabilities
Liabilities
329761000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77285000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77285000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74624000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74624000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
78000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
75000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
934585000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
891681000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-841000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1336000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-491702000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-487182000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
442120000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
403238000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
742422000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
732999000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118805000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101575000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31934000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31573000
CY2024Q3 us-gaap Gross Profit
GrossProfit
86871000
CY2023Q3 us-gaap Gross Profit
GrossProfit
70002000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32427000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28496000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37760000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34419000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23938000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21052000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
94125000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
83967000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7254000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13965000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3422000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-943000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3832000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14908000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
688000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4520000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-15321000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75604000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75604000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68937000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68937000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4520000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-15321000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
495000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-291000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
495000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-291000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4025000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15612000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
403238000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22918000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19989000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
495000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4520000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
442120000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
341208000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2324000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18757000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-291000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-15321000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
346673000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-4520000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-15321000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4467000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4009000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1280000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1130000
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
550000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
425000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
19989000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
18757000
CY2024Q3 inta Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-1004000
CY2023Q3 inta Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-1431000
CY2024Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-48000
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-113000
CY2024Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-38000
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-38000
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-30207000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23472000
CY2024Q3 inta Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
-523000
CY2023Q3 inta Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
3886000
CY2024Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2568000
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1342000
CY2024Q3 inta Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
1667000
CY2023Q3 inta Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
121000
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8060000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11277000
CY2024Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-17275000
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
222000
CY2024Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1331000
CY2023Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1571000
CY2024Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
531000
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1621000
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24446000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11612000
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
354000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1141000
CY2024Q3 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1534000
CY2023Q3 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1861000
CY2024Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
897000
CY2023Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2785000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3002000
CY2024Q3 inta Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
0
CY2023Q3 inta Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
633000
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22918000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2324000
CY2024Q3 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1387000
CY2023Q3 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21531000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1691000
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2285000
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
261000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45477000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10562000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
208570000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
131185000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
254047000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
141747000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253847000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141547000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
254047000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141747000
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
0
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
529000
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
128000
CY2024Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
45000
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
175000
CY2024Q3 inta Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities
CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities
742000
CY2023Q3 inta Capitalized Internal Use Software Costs In Accounts Payable And Accrued Liabilities
CapitalizedInternalUseSoftwareCostsInAccountsPayableAndAccruedLiabilities
0
CY2023Q3 inta Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
146000
CY2024Q3 inta Deferred Consideration And Acquisition Holdbacks Included In Accounts Payable Accrued Liabilities And Other Liabilities
DeferredConsiderationAndAcquisitionHoldbacksIncludedInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
3695000
CY2023Q3 inta Deferred Consideration And Acquisition Holdbacks Included In Accounts Payable Accrued Liabilities And Other Liabilities
DeferredConsiderationAndAcquisitionHoldbacksIncludedInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
8374000
CY2024Q3 us-gaap Nature Of Operations
NatureOfOperations
<p id="note_1_description_of_business" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1. Description of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Intapp, Inc. ("Intapp" or the "Company") is a leading global provider of AI-powered solutions for professionals at advisory, capital markets and legal firms. The Company empowers the world’s premier accounting, consulting, investment banking, legal, private capital and real assets firms with the technology they need to operate more competitively, deliver timely insights to their professionals, and meet rapidly changing client, investor, and regulatory requirements. Using the power of Applied AI, its purpose-built vertical software as a service (“SaaS”) solutions accelerate the flow of information firmwide, activate expertise, empower teams, strengthen client relationships, manage risk, and help firms adapt more quickly in a highly complex ecosystem. The Company serves clients primarily in the United States (“U.S.”) and the United Kingdom (“U.K.”). References to “the Company,” “us,” “we,” or “our” in these unaudited condensed consolidated financial statements refer to the consolidated operations of Intapp and its consolidated subsidiaries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the unaudited condensed consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, revenue recognition including determination of the standalone selling price (“SSP”) of the deliverables included in multiple deliverable revenue arrangements; allowance for credit losses; the depreciable lives of long-lived assets including intangible assets; the expected useful life of deferred commissions; the fair value of stock-based awards; the fair value of assets acquired and liabilities assumed in business combinations; goodwill and long-lived assets impairment assessment; the fair value of contingent consideration liabilities; the incremental borrowing rate used to determine the operating lease liabilities; valuation allowances on deferred tax assets; uncertain tax positions; and loss contingencies. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the unaudited condensed consolidated financial statements.</span>
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk and Significant Clients</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents with multiple high credit quality financial institutions. The Company is exposed to credit risk for cash and cash equivalents held in financial institutions to the extent that such amounts recorded on the balance sheet are in excess of amounts that are insured by the Federal Deposit Insurance Corporation. The Company has not experienced any such losses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> client individually accounted for 10% or more of the Company’s revenues for either of the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three months ended September 30, 2024 and 2023. As of September 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> client individually accounted for 10% or more of the Company’s total accounts receivable. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> client individually accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s total accounts receivable.</span></p>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118805000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101575000
CY2024Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
30700000
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
32400000
CY2024Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2024Q3 inta Unbilled Receivables Current And Noncurrent
UnbilledReceivablesCurrentAndNoncurrent
12979000
CY2024Q2 inta Unbilled Receivables Current And Noncurrent
UnbilledReceivablesCurrentAndNoncurrent
13363000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
205211000
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
222486000
CY2024Q3 inta Unbilled Receivables Noncurrent
UnbilledReceivablesNoncurrent
202000
CY2024Q2 inta Unbilled Receivables Noncurrent
UnbilledReceivablesNoncurrent
63000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
88500000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
65300000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
549400000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.56
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q2 us-gaap Goodwill
Goodwill
285969000
CY2024Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
503000
CY2024Q3 us-gaap Goodwill
Goodwill
286472000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
127896000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
90605000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37291000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
127896000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87603000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40293000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3002000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2705000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8161000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7835000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5121000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4623000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3252000
CY2024Q3 inta Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
3616000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32608000
CY2024Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1600000
CY2023Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1500000
CY2024Q3 inta Net Book Value Of Capitalized Software Development Costs
NetBookValueOfCapitalizedSoftwareDevelopmentCosts
14200000
CY2024Q2 inta Net Book Value Of Capitalized Software Development Costs
NetBookValueOfCapitalizedSoftwareDevelopmentCosts
13500000
CY2024Q3 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
0
CY2023Q3 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
0
CY2024Q3 inta Capitalized Cloud Computing Implementation Cost
CapitalizedCloudComputingImplementationCost
800000
CY2023Q3 inta Capitalized Cloud Computing Implementation Cost
CapitalizedCloudComputingImplementationCost
1000000
CY2024Q3 inta Capitalized Cloud Computing Implementation Cost Amortization
CapitalizedCloudComputingImplementationCostAmortization
100000
CY2023Q3 inta Capitalized Cloud Computing Implementation Cost Amortization
CapitalizedCloudComputingImplementationCostAmortization
0
CY2024Q3 inta Net Book Value Of Capitalized Cloud Computing Implementation Costs
NetBookValueOfCapitalizedCloudComputingImplementationCosts
4800000
CY2024Q2 inta Net Book Value Of Capitalized Cloud Computing Implementation Costs
NetBookValueOfCapitalizedCloudComputingImplementationCosts
4100000
CY2024Q3 inta Capitalized Cloud Computing Implementation Costs Impairment
CapitalizedCloudComputingImplementationCostsImpairment
0
CY2023Q3 inta Capitalized Cloud Computing Implementation Costs Impairment
CapitalizedCloudComputingImplementationCostsImpairment
0
CY2024Q3 inta Lessee Operating Lease Expiration Year
LesseeOperatingLeaseExpirationYear
2030
CY2024Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1705000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1500000
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
192000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
271000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
116000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2151000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1695000
CY2024Q3 inta Increase Decrease Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-70000
CY2023Q3 inta Increase Decrease Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5600000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6000000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5425000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5365000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4380000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4687000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5124000
CY2024Q3 inta Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3828000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28809000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4603000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
24206000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6866000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.40
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
180360000
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2038000
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.24
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13000
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
23.23
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4815000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.01
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
182100000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4670000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.66
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
178262000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4815000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.01
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
182100000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19989000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18757000
CY2024Q3 inta Modification And Increase In Unrecognized Stock Based Compensation Expense
ModificationAndIncreaseInUnrecognizedStockBasedCompensationExpense
14800000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200700000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4520000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-15321000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75604000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75604000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68937000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68937000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12147000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17289000

Files In Submission

Name View Source Status
0000950170-24-123292-index-headers.html Edgar Link pending
0000950170-24-123292-index.html Edgar Link pending
0000950170-24-123292.txt Edgar Link pending
0000950170-24-123292-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inta-20240930.htm Edgar Link pending
inta-20240930.xsd Edgar Link pending
inta-ex31_1.htm Edgar Link pending
inta-ex31_2.htm Edgar Link pending
inta-ex32_1.htm Edgar Link pending
inta-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
inta-20240930_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable